Yüklüyor......
Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type
SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) protein is the target for the antiviral drug Remdesivir (RDV). With RDV clinical trials on COVID-19 patients showing a reduced hospitalisation time. During the spread of the virus, the RdRp has developed several mutations, with the most frequent being A...
Kaydedildi:
| Yayımlandı: | Biomolecules |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301449/ https://ncbi.nlm.nih.gov/pubmed/34206274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom11070919 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|